Workflow
DOMA Perpetual Nominates Three Highly Qualified Candidates for the Board of Pacira BioSciences
PaciraPacira(US:PCRX) Prnewswire·2025-03-14 20:25

Pacira's Stock is Down 76% Over the Last Decade, While the Board and Management Have Enriched Themselves at a Cost of Half a Billion Dollars, Roughly 50% of the Current Market CapUnder CEO and Board Member Frank Lee, the Stock Price Has Declined 33%; He is Pushing for Higher Compensation Packages for Management While Burdening Shareholders with New Risks; DOMA Believes His Views on Capital Allocation Are Misaligned With Shareholder Interest and He Has No Track Record of Creating Shareholder ValueChange to t ...